PER 1.27% 8.0¢ percheron therapeutics limited

Ann: Antisense Therapeutics appoints new Non-Executive Director, page-16

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,989 Posts.
    lightbulb Created with Sketch. 130
    Sounds like a smart move bringing in Charmaine. A lady of her background and experience would imv not take on such a role if she did not see the potential in what the Co. is tapping into here. DMD may well be the tip for many others.

    I am not sure I would be waiting out for 14c to come around again as I am not sure that will happen. It may though there i believe there is too much coming at ANP.

    These appointments I hope will deflect from other areas where ANP lacks expertise.
    And I refer to Goolsbee; Price and Gittleson

    Good luck
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.001(1.27%)
Mkt cap ! $82.94M
Open High Low Value Volume
8.0¢ 8.3¢ 7.9¢ $461.5K 5.711M

Buyers (Bids)

No. Vol. Price($)
6 844186 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 292500 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.